Rhamnogalacturonan-I Based Microcapsules for Targeted Drug Release

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Dec 20

PMID 27992455

Citations 5

Authors

Anna J Svagan

Anja Kusic

Cristian De Gobba

Flemming H Larsen

Philip Sassene

Qi Zhou

Marco van de Weert

Anette Mullertz

Bodil JOrgensen

Peter Ulvskov

Affiliations

Soon will be listed here.

Abstract

Drug targeting to the colon via the oral administration route for local treatment of e.g. inflammatory bowel disease and colonic cancer has several advantages such as needle-free administration and low infection risk. A new source for delivery is plant-polysaccharide based delivery platforms such as Rhamnogalacturonan-I (RG-I). In the gastro-intestinal tract the RG-I is only degraded by the action of the colonic microflora. For assessment of potential drug delivery properties, RG-I based microcapsules (~1 μm in diameter) were prepared by an interfacial poly-addition reaction. The cross-linked capsules were loaded with a fluorescent dye (model drug). The capsules showed negligible and very little in vitro release when subjected to media simulating gastric and intestinal fluids, respectively. However, upon exposure to a cocktail of commercial RG-I cleaving enzymes, ~ 9 times higher release was observed, demonstrating that the capsules can be opened by enzymatic degradation. The combined results suggest a potential platform for targeted drug delivery in the terminal gastro-intestinal tract.

Citing Articles

Fibrin-Rhamnogalacturonan I Composite Gel for Therapeutic Enzyme Delivery to Intestinal Tumors.

Faizullin D, Valiullina Y, Salnikov V, Zelenikhin P, Zuev Y, Ilinskaya O Int J Mol Sci. 2023; 24(2).

PMID: 36674440 PMC: 9862006. DOI: 10.3390/ijms24020926.

Components of the Fiber Diet in the Prevention and Treatment of IBD-An Update.

Ferenc K, Jarmakiewicz-Czaja S, Filip R Nutrients. 2023; 15(1).

PMID: 36615818 PMC: 9823509. DOI: 10.3390/nu15010162.

The Effect of Water-Soluble Polysaccharide from Jackfruit ( Lam.) on Human Colon Carcinoma Cells Cultured In Vitro.

Wiater A, Paduch R, Trojnar S, Choma A, Pleszczynska M, Adamczyk P Plants (Basel). 2020; 9(1).

PMID: 31947694 PMC: 7020216. DOI: 10.3390/plants9010103.

Oral Drug Delivery Technologies-A Decade of Developments.

Kaur G, Arora M, Kumar M J Pharmacol Exp Ther. 2019; 370(3):529-543.

PMID: 31010845 PMC: 6806634. DOI: 10.1124/jpet.118.255828.

Fruit-Derived Polysaccharides and Terpenoids: Recent Update on the Gastroprotective Effects and Mechanisms.

Khan M, Khundmiri S, Khundmiri S, Al-Sanea M, Mok P Front Pharmacol. 2018; 9:569.

PMID: 29988459 PMC: 6024987. DOI: 10.3389/fphar.2018.00569.

References

Thomassen L, Larsen D, Mikkelsen J, Meyer A . Definition and characterization of enzymes for maximal biocatalytic solubilization of prebiotic polysaccharides from potato pulp. Enzyme Microb Technol. 2011; 49(3):289-97. DOI: 10.1016/j.enzmictec.2011.06.006. View

Vertzoni M, Dressman J, Butler J, Hempenstall J, Reppas C . Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. Eur J Pharm Biopharm. 2005; 60(3):413-7. DOI: 10.1016/j.ejpb.2005.03.002. View

Molgaard S, Henriksson M, Cardenas M, Svagan A . Cellulose-nanofiber/polygalacturonic acid coatings with high oxygen barrier and targeted release properties. Carbohydr Polym. 2014; 114:179-182. DOI: 10.1016/j.carbpol.2014.08.011. View

Maxwell E, Colquhoun I, Chau H, Hotchkiss A, Waldron K, Morris V . Rhamnogalacturonan I containing homogalacturonan inhibits colon cancer cell proliferation by decreasing ICAM1 expression. Carbohydr Polym. 2015; 132:546-53. DOI: 10.1016/j.carbpol.2015.06.082. View

Baier G, Musyanovych A, Dass M, Theisinger S, Landfester K . Cross-linked starch capsules containing dsDNA prepared in inverse miniemulsion as "nanoreactors" for polymerase chain reaction. Biomacromolecules. 2010; 11(4):960-8. DOI: 10.1021/bm901414k. View

Assifaoui A, Bouyer F, Chambin O, Cayot P . Silica-coated calcium pectinate beads for colonic drug delivery. Acta Biomater. 2012; 9(4):6218-25. DOI: 10.1016/j.actbio.2012.11.031. View

Schols H, Voragen A, Colquhoun I . Isolation and characterization of rhamnogalacturonan oligomers, liberated during degradation of pectic hairy regions by rhamnogalacturonase. Carbohydr Res. 1994; 256(1):97-111. DOI: 10.1016/0008-6215(94)84230-2. View

Zangenberg N, Mullertz A, Kristensen H, Hovgaard L . A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. Eur J Pharm Sci. 2001; 14(2):115-22. DOI: 10.1016/s0928-0987(01)00169-5. View

Marquis M, Davy J, Cathala B, Fang A, Renard D . Microfluidics assisted generation of innovative polysaccharide hydrogel microparticles. Carbohydr Polym. 2014; 116:189-99. DOI: 10.1016/j.carbpol.2014.01.083. View

10.

Alvarez-Lorenzo C, Blanco-Fernandez B, Puga A, Concheiro A . Crosslinked ionic polysaccharides for stimuli-sensitive drug delivery. Adv Drug Deliv Rev. 2013; 65(9):1148-71. DOI: 10.1016/j.addr.2013.04.016. View

11.

Svagan A, Bender Koch C, Hedenqvist M, Nilsson F, Glasser G, Baluschev S . Liquid-core nanocellulose-shell capsules with tunable oxygen permeability. Carbohydr Polym. 2015; 136:292-9. DOI: 10.1016/j.carbpol.2015.09.040. View

12.

Orfila C, Dal Degan F, JOrgensen B, Scheller H, Ray P, Ulvskov P . Expression of mung bean pectin acetyl esterase in potato tubers: effect on acetylation of cell wall polymers and tuber mechanical properties. Planta. 2012; 236(1):185-96. DOI: 10.1007/s00425-012-1596-z. View

13.

Humblet-Hua N, Linden E, Sagis L . Microcapsules with protein fibril reinforced shells: effect of fibril properties on mechanical strength of the shell. J Agric Food Chem. 2012; 60(37):9502-11. DOI: 10.1021/jf3024529. View

14.

El-Gibaly I . Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery. Int J Pharm. 2002; 232(1-2):199-211. DOI: 10.1016/s0378-5173(01)00903-6. View

15.

Carriere F, Barrowman J, Verger R, Laugier R . Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology. 1993; 105(3):876-88. DOI: 10.1016/0016-5085(93)90908-u. View

16.

Bergstrom C, Holm R, Jorgensen S, Andersson S, Artursson P, Beato S . Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. Eur J Pharm Sci. 2013; 57:173-99. DOI: 10.1016/j.ejps.2013.10.015. View

17.

Armand M, Borel P, Pasquier B, Dubois C, Senft M, Andre M . Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am J Physiol. 1996; 271(1 Pt 1):G172-83. DOI: 10.1152/ajpgi.1996.271.1.G172. View

18.

Manderson K, Pinart M, Tuohy K, Grace W, Hotchkiss A, WIDMER W . In vitro determination of prebiotic properties of oligosaccharides derived from an orange juice manufacturing by-product stream. Appl Environ Microbiol. 2005; 71(12):8383-9. PMC: 1317361. DOI: 10.1128/AEM.71.12.8383-8389.2005. View

19.

Sassene P, Kleberg K, Williams H, Bakala-NGoma J, Carriere F, Calderone M . Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels. AAPS J. 2014; 16(6):1344-57. PMC: 4389749. DOI: 10.1208/s12248-014-9672-x. View

20.

Zhang M, Chekan J, Dodd D, Hong P, Radlinski L, Revindran V . Xylan utilization in human gut commensal bacteria is orchestrated by unique modular organization of polysaccharide-degrading enzymes. Proc Natl Acad Sci U S A. 2014; 111(35):E3708-17. PMC: 4156774. DOI: 10.1073/pnas.1406156111. View